Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer

Acta Oncologica

Volumn 47, Issue 5, 2008, Pages 954-961

  Kepka, Lucyna ^a   Bujko, Krzysztof ^a   Zolciak Siwinska, Agnieszka ^a   Garmol, Dariusz ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER THERAPY; CONTROLLED STUDY; HUMAN; IRRADIATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; LYMPH NODES; MEDIASTINUM; PROSPECTIVE STUDIES; RADIOTHERAPY, CONFORMAL;

EID: 45849133829     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701654317     Document Type: Article

References (24)

1. Belderbos JSA, Heemsbergen WD, De Jaeger K, et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:126-34.
2. Bradley JD, Wahab S, Lockett MA, et al. Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 2003;56:342-7.
3. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61:318-28.
4. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol 2001;19:127-36.
5. Krol AD, Aussems P, Noordijk EM, et al. Local irradiation alone for peripheral stage I lung cancer - could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996;34:297-302.
6. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-5.
7. Rosenzweig KE, Fox JL, Yorke E, et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung carcinoma. Cancer 2005;103:2118-27.
8. Rosenzweig KE, Sim SE, Mychalczak B, et al. Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:681-5.
9. Senan S, Burgers S, Samson MJ, et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:999-1006.
10. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radioherapy for stage I (T1-2N0M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006;45:796-801.
11. Jeremic B. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in non-small cell lung cancer (NSCLC): Enough to convert no-elective into elective nodal irradiation (ENI)? Radiother Oncol 2003;71:123-5.
12. Kepka L, Bujko K, Zolciak-Siwinska A. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques. Acta Oncol 2007; (in press).
13. Chen M, Hayman JA, Ten Haken RK, et al. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys 2006;64:120-6.
14. Martel MK, Sahidjdak WM, Hayman JA, et al. Incidental dose to clinically negative nodes from conformal treatment fields for non small cell lung cancer. Int J Radiat Oncol Biol Phys 1999;45:S244 (abstract).
15. Chapet O, Kong F-M, Quint LE, et al. CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 2005;63:170-8.
16. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23.
17. Asamura H, Nakayama H, Kondo H, et al. Lobe-specific extent of systemic lymph node dissection for non-small cell lung carcinoma according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg 1999;117:1102-11.
18. Giraud P, De Rycke Y, Lavole A, et al. Probability of mediastinal involvement in non-small-cell lung cancer: A statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? Int J Radiat Oncol Biol Phys 2006;64:127-35.
19. Kotoulas CS, Foroulis CN, Kostikas K, et al. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer 2004;44:183-91.
20. Kelsey CR, Light KL, Marks LB. Patterns of failure after resection of non-small-cell Lung Cancer: Implications for postoperative radiation therapy volume. Int J Radiat Oncol Biol Phys 2006;65:1097-105.
21. Withers HR, Peters LJ, Taylor JMG. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 1995;31:353-9.
22. Suwinski R, Withers HR. Time factor and treatment strategies in subclinical disease. Int J Radiat Biol 2003;79:495-502.
23. Withers HR, Suwinski R. Radiation dose response for subclinical metastases. Sem Radiat Oncol 1998;8:224-8.
24. Joiner MC, Marples B, Lambin P, et al. Low-dose hypersensitivity: Current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001;49:379-89.